Latest literature | Zhongnan Medical Journal Press

Home Literature Latest literature

Latest literature

Bibliometric analysis of medication safety studies in pediatric atopic dermatitis

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):679-688.
323 times 108 times

WEI Fenfang HUANG Leyi LI Limin WU Jianru LIU Xiaoyu

Children Eczema Atopic dermatitis Safe medication Bibliometrics
Details
Efficacy and safety of galcanezumab in the treatment of migraine in adults: a systematic review and Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):669-678.
319 times 82 times

HE Xiaodong LI Qin KE Changhu LI Chunlei LIU Huimin

Galcanezumab Migraine Randomized controlled trial Systematic review Meta-analysis
Details
Real-world study of generic versus branded meropenem in the treatment of hospital-acquired pneumonia patients with traumatic brain injury

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):660-668.
293 times 79 times

SHEN Jie TANG Lian CHEN Xianglong YANG Lijuan LI Tongtong MA Mian DENG Peng XU Jinhui

Meropenem Generic drug Branded drug Hospital-acquired pneumonia Traumatic brain injury Efficacy Safety Economy
Details
Post-marketing safety evaluation of nirsevimab based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):653-659.
366 times 77 times

NIU Rui LIU Wei ZHAO Kai ZHANG Wenqian ZHAO Fang

Nirsevimab Respiratory syncytial virus Pharmacovigilance Adverse drug reactions
Details
Analysis of the association between analgesic drug use and asthma in different body fat levels: a cross-sectional study based on NHANES

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):645-652.
276 times 83 times

ZHANG Sisi WANG Wutao HAN Bin ZHAO Ling LI Zhengwei QIAO Yan ZHANG Lei

Opioid analgesics Non-opioid analgesics Asthma Percent fat Associavtion NHANES
Details
Survey on knowledge, attitudes, and practices among residents in the Ningxia and analysis of influencing factors

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):635-644.
272 times 75 times

SUN Lixia ZHANG Xiaoli JI Hongyan

Knowledge-attitude-practice Medication risks Medication safety Influencing factors
Details
Development of a predictive model for the risk of antimicrobial drug-induced thrombocytopenia using 5 machine learning algorithms

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):625-634.
292 times 74 times

WANG Min SHEN Xiaoyan

Machine learning Antimicrobial drugs Thrombocytopenia Prediction model Risk factors Extreme gradient boosting SHapley Additive exPlanation
Details
Interpretation of the Transparent Reporting of Observational Studies Emulating a Target Trial (TARGET) statement

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):613-624.
296 times 75 times

LIN Tengfei WU Xiaoyu HE Na LONG Yujun YANG Nan QIU Yijin ZHANG Tiantian XU Yang YANG Zhirong

Observational study Target trial emulation Reporting guideline TARGET statement Causal inference
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (18): analysis strategies and clinical applications of heterogeneity of treatment effect

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):601-612.
312 times 89 times

HUANG Tao SHEN Zhuoheng XU Yang

Heterogeneity of treatment effect Pharmacoepidemiology Real-world data Subgroup analysis Risk modelling Effect modelling Causal machine learning Precision medicine
Details
Analysis of one case of almolertinib-induced interstitial lung disease in a lung cancer patient

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):895-900.
804 times 150 times

FAN Xinxing LI Ling ZHENG Menying BAI Juan

Almonertinib Interstitial lung disease Lung cancer Adverse drug reaction
Details
Interpretation of the Guiding Principles of Good AI Practice in Drug Development jointly released by FDA and EMA

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):885-894.
1558 times 554 times

ZHANG Hua LI Pengfei FU Hongjun

U.S. Food and Drug Administration European Medicines Agency Ar-tificial intelligence Drug development Guide principles Regulatory science
Details
Research progress on optimized technical paths of meloxicam dosage forms

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):876-884.
705 times 136 times

YANG Jie YUAN Jing XU Shaohua LIAO Zongquan XIAO Gaofeng QU Longmei

Meloxicam Dosage form Drug delivery system Targeted preparations Sustained-release preparations Cyclooxygenase-2
Details
Research progress on traditional Chinese medicine combined with chemotherapeutic drugs in the treatment of colorectal cancer

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):867-875.
775 times 132 times

LIU Qingrui WANG Lu CHEN Hao WANG Pei HUANG Chuyue ZHOU Bingwen DONG Yujing FAN Zhimin

Colorectal cancer Traditional Chinese medicine Enhancing efficacy and reducing toxicity Cell cycle Autophagy Apoptosis Multidrug resistance Immune microenvironment
Details
Research progress on multidrug resistance mechanism of non-small cell lung cancer and reversal effect of active ingredients of traditional Chinese medicine

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):857-866.
800 times 147 times

ZHENG Wanrong LAI Fobao

Tumor multidrug resistance Non-small cell lung cancer Active components of traditional Chinese medicine Resistance reversal Non-coding RNA Programmed cell death
Details
Research progress on clinical application and mechanisms of traditional Chinese medicine formulas in postpartum hypogalactia

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):848-856.
916 times 142 times

CHENG Kun FU Xianjun LI Xiuxue

Postpartum hypogalactia Traditional Chinese medicine formulas Clinical research Syndrome differentiation Mechanism of action
Details
Research progress on food-medicine homology substances in metabolic dysfunc-tion-associated steatotic liver disease

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):839-847.
972 times 168 times

SUN Mingyu LI Ming ZHANG Hao

Food-medicine homology substances Metabolic dysfunction-associated steatotic liver disease Lipid metabolism Liver fibrosis Mechanism of action
Details
Research progress on herbal textual research and pharmacological effects of Changium smyrnioides Wolff

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):828-838.
990 times 185 times

DOU Haoran LIU Yu YI Bowen

Changium smyrnioides Wolff Processing Efficacy Herbal textual research Pharmacological effects
Details
Establishment of drug utilization evaluation criteria for bemiparin sodium and its clinical application

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):820-827.
845 times 158 times

YE Chenli HONG Weimin HAN Yutong CAO Weiling

Bemiparin sodium Drug utilization evaluation Delphi method Off-label use Rational drug use
Details
Retrospective study on the efficacy of insulin degludec/insulin aspart combined with dietary management in patients with type 2 diabetes mellitus

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):813-819.
839 times 155 times

XIANG Yuyang XIE Yuye LIN Zhihao

Type 2 diabetes mellitus Insulin degludec/insulin aspart Integrated diet management model Efficacy observation
Details
Simultaneous determination of 10 impurities in ibuprofen and its preparations by UPLC method

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):804-812.
864 times 157 times

YUN Xiaofei ZHANG Yanxia QIAN Yujuan HAN Feng XIAO Honghua YAN Zeman WANG Meng

Ibuprofen Ultra-performance liquid chromatography Impurities Toxicity Quality control
Details